Healthcare provider profile · identity verified

Travis E. Rasor, D.O.

Family Practice · MAUMEE, OH · NPI 1215918446

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	615	172
Lisinopril	Lisinopril	366	90
Omeprazole	Omeprazole	335	83
Levothyroxine Sodium	Levothyroxine Sodium	333	83
Losartan Potassium	Losartan Potassium	331	79
Amlodipine Besylate	Amlodipine Besylate	302	74
Rosuvastatin Calcium	Rosuvastatin Calcium	263	70
Hydrochlorothiazide	Hydrochlorothiazide	231	63
Sertraline Hcl	Sertraline Hcl	218	46
Alprazolam	Alprazolam	213	53
Gabapentin	Gabapentin	207	60
Pantoprazole Sodium	Pantoprazole Sodium	198	44
Metoprolol Succinate	Metoprolol Succinate	196	61
Tamsulosin Hcl	Tamsulosin Hcl	181	45
Simvastatin	Simvastatin	179	53
Metformin Hcl Er	Metformin Hcl	170	37
Meloxicam	Meloxicam	169	45
Trazodone Hcl	Trazodone Hcl	142	24
Tramadol Hcl	Tramadol Hcl	139	33
Metformin Hcl	Metformin Hcl	114	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	111	28
Allopurinol	Allopurinol	106	31
Paroxetine Hcl	Paroxetine Hcl	105	20
Furosemide	Furosemide	101	34
Metoprolol Tartrate	Metoprolol Tartrate	99	27
Carvedilol	Carvedilol	97	23
Pravastatin Sodium	Pravastatin Sodium	96	23
Alendronate Sodium	Alendronate Sodium	92	23
Potassium Chloride	Potassium Chloride	92	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	91	17
Famotidine	Famotidine	85	22
Zolpidem Tartrate	Zolpidem Tartrate	85	25
Prednisone	Prednisone	82	55
Tizanidine Hcl	Tizanidine Hcl	81	22
Synthroid	Levothyroxine Sodium	78	22
Atenolol	Atenolol	77	21
Citalopram Hbr	Citalopram Hydrobromide	74	17
Lorazepam	Lorazepam	74	17
Duloxetine Hcl	Duloxetine Hcl	73	15
Eszopiclone	Eszopiclone	73	11
Fluticasone Propionate	Fluticasone Propionate	73	28
Fenofibrate	Fenofibrate	71	21
Eliquis	Apixaban	63	17
Montelukast Sodium	Montelukast Sodium	62	21
Ropinirole Hcl	Ropinirole Hcl	59	suppressed
Clopidogrel	Clopidogrel Bisulfate	58	13
Ezetimibe	Ezetimibe	58	15
Raloxifene Hcl	Raloxifene Hcl	57	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	56	12
Januvia	Sitagliptin Phosphate	55	suppressed
Ibuprofen	Ibuprofen	54	17
Escitalopram Oxalate	Escitalopram Oxalate	53	14
Pioglitazone Hcl	Pioglitazone Hcl	50	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	14
Pregabalin	Pregabalin	49	13
Bupropion Xl	Bupropion Hcl	45	suppressed
Lovastatin	Lovastatin	44	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	11
Donepezil Hcl	Donepezil Hcl	41	11
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Farxiga	Dapagliflozin Propanediol	36	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	36	25
Albuterol Sulfate Hfa	Albuterol Sulfate	35	19
Tolterodine Tartrate Er	Tolterodine Tartrate	35	suppressed
Finasteride	Finasteride	33	suppressed
Azithromycin	Azithromycin	32	25
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Fluconazole	Fluconazole	30	14
Glipizide Er	Glipizide	30	11
Warfarin Sodium	Warfarin Sodium	29	suppressed
Amoxicillin	Amoxicillin	27	12
Bumetanide	Bumetanide	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Valsartan	Valsartan	27	suppressed
Glimepiride	Glimepiride	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	12
Ozempic	Semaglutide	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	15
Jantoven	Warfarin Sodium	24	suppressed
Primidone	Primidone	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Cefuroxime	Cefuroxime Axetil	21	21
Celecoxib	Celecoxib	21	suppressed
Diazepam	Diazepam	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	19
Repatha Sureclick	Evolocumab	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Irbesartan	Irbesartan	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Carisoprodol	Carisoprodol	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Zolmitriptan	Zolmitriptan	18	suppressed
Alprazolam Er	Alprazolam	17	suppressed
Estradiol (Once Weekly)	Estradiol	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	16	suppressed
Lithium Carbonate	Lithium Carbonate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	11
Acarbose	Acarbose	15	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	15	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Glipizide	Glipizide	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Tadalafil	Tadalafil	14	suppressed
Temazepam	Temazepam	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Nystatin	Nystatin	13	suppressed
Penicillin V Potassium	Penicillin V Potassium	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Ramipril	Ramipril	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Baclofen	Baclofen	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Estradiol	Estradiol	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Singulair	Montelukast Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error